A NOVEL ANTI-CD24-TOXIN IMMUNOCONJUGATE FOR TARGETED CANCER THERAPY

(1) Integrated Cancer Prevention Center, Tel Aviv Medical Center and Tel Aviv University

(2) Integrated Cancer Prevention Center, Tel Aviv Medical Center

(3) Dept. of Molecular Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel

(4) Tumor Immunology, German Cancer Research Center, Heidelberg, Germany

(5) Dept. of Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel



This item was part of the Novel agents for treatment and prevention of colorectal cancer session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A68

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2009